<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563200/" ref="ordinalpos=3025&amp;ncbi_uid=4616856&amp;link_uid=PMC3563200" image-link="/pmc/articles/PMC3563200/figure/fig04/" class="imagepopup">Figure 4.  From: Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">IDO1 inhibits p53 expression through JNK signaling pathway. The transfected ESCs were treated with JNK inhibitor (SP600125, 20 μM) or vehicle control (1‰ DMSO) for 24 h. Thereafter, the expressions of proliferation associated proteins survivin (A), p53 (B) were determined by in-cell Western. The columns represent the mean ± SD calculus of 8 different experiments. *P&lt;.05 vs. vector control transfected ESCs without SP600125; **P&lt;.01 vs. vector control transfected ESCs without SP600125; #P&lt;.05, IDO1-overexpressing ESCs with SP600125 vs. IDO1-overexpressing ESCs without SP600125.</div></div>